Five recent Parkinson’s disease drug target discoveries
This article highlights five of the latest findings that could be used in the development or design of new therapies to treat Parkinson’s disease.
List view / Grid view
This article highlights five of the latest findings that could be used in the development or design of new therapies to treat Parkinson’s disease.
A potential target for ALS has been revealed by a study which found the Fos-B gene encouraged axonal branching.
It has been discovered that Id4 controls whether stem cells enter cell division and may be relevant for treating neurodegenerative disease.
MSD and the Francis Crick Institute will work together on a project to identify disease targets for motor neuron disease.
A study has discovered the regulating process behind cell autophagy which could aid in the development of neurodegenerative disease treatments.
Researchers have found that the presence of microglia brain cells allowed plaques to form in the brains of rodents, leading to Alzheimer’s disease.
Researchers may have fundamentally altered the way scientists study brain diseases with new CRISPR technology.
A study has discovered a molecule key in neuronal growth that could be used as a drug target to treat anxiety-related diseases.
A new study has found that damage caused by Alzheimer's allows toxins to enter the brain, further harming neurons.
New research into sex-based differences of Parkinson's disease could lead to new treatments.
The cause and trigger of the large clumps of protein beta-amyloid found in the brains of early-stage Alzheimer's patients have been discovered.
New discovery makes it possible to design new therapies to replace alpha-synuclein's function in people with Parkinson's disease.
A study has discovered that the damage of projection neurons in the brain is caused by immune cells, leading to MS.
Researchers have discovered that the VPS35 molecule can be utilised in preventing neurodegenerative disorders.
Researchers prove it's possible to control a visual behaviour of a mouse by activating neurons in its visual cortex.